Enhancing the VP Echelon product line, Biocare is pleased to announce the addition of p40 mouse monoclonal, Arginase-1, and Uroplakin II to our menu of prediluted antibodies optimized for the Ventana® BenchMark® XT Immunohistochemistry Staining Systems. The mouse monoclonal antibody p40 [BC28] may have applications in cases where p63 is used. While p63 has proven […]
Biocare Medical is proud to announce the availability of a new highly specific p40 mouse monoclonal antibody (IVD). Mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity as the rabbit polyclonal p40, staining 97% (65/67) of cases of lung squamous cell carcinoma (SqCC) and 0% (0/71) cases of lung adenocarcinoma (ADC), in an in-house study. […]
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have […]
-New Assay, Developed in Collaboration with Morphotek, Uses Proprietary Technology- Concord, CA and Exton, PA, March 20, 2012 – In partnership with Morphotek® Inc., a subsidiary of Eisai Inc., Biocare Medical announced the release of its in vitro diagnostic immunohistochemical (IHC) kit to detect folate receptor alpha (FRalpha) expression in formalin fixed paraffin embedded (FFPE) […]
Biocare Medical proudly introduces four newly developed horseradish peroxidase (HRP) and alkaline phosphatase (AP) polymer detection systems for horse, cow, pig and sheep tissues. These Mouse-on-Farma and Rabbit-on-Farma HRP and AP polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies. The advanced polymer technology virtually eliminates cross-reactivity to […]
Biocare Medical Ranks No. 2781 on the 2011 Inc. 500 | 5000 with Three-Year Sales Growth of 79% Concord, CA, October 10, 2011 – Biocare Medical ranked No. 2781 in Inc. Magazine’s fifth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. This represents the third consecutive year that Biocare Medical has […]
Biocare Medical is proud to announce the launch of a mouse monoclonal PAX8 antibody. Unlike current existing PAX8 polyclonals, the PAX8 mouse clone [BC12] has been designed for specific epitope targeting. The monoclonal PAX8 does not stain B-cells, cells of pancreatic origin or neuroendocrine cells of the stomach or colon. This antibody also has lower […]
Biocare Medical is proud to announce the launch of the PulmoPanel™ Multiplex IHC to clearly differentiate between adenocarcinoma (LADC) and squamous cell carcinoma (SqCC) of the lung with 97% specificity and 93% sensitivity. This Multiplex IHC contains six antibodies (TTF-1, Napsin A, p63, TRIM29, Desmoglein 3 and CK5), and aids in the critical differentiation of […]
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC. Under the agreement, the parties will collaborate to develop and commercialize an immunohistochemical (IHC) diagnostic kit utilizing Morphotek’s proprietary monoclonal antibody to specifically detect human folate receptor alpha (FRA) with Biocare’s intelliPATH™ […]
Biocare Medical is proud to announce the launch of the anti-ERG monoclonal antibody (clone 9FY CPDR) for in-vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. The ERG oncoprotein is a promising diagnostic marker for identifying prostatic adenocarcinoma and distinguishing it from non-neoplastic prostate and other adenocarcinomas. This ERG antibody is 99.6% specific for prostate […]